Registry data on patients with type 1 diabetes mellitus who undergo pancreatic islet transplantation indicate that only 8 percent are free of the need for insulin therapy at one year. All seven ...

Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, kidney failure, cancer, and Alzheimer's disease. At the heart of this ...

I'm talking about the advancement of islet pancreatic cells being deployed to help treat patients with Type 1 Diabetes [T1D]. There were positive results released from a candidate in the pipeline ...

Sana Biotechnology’s genetically engineered pancreatic islet cells controlled glucose levels for six months in a diabetic primate without requiring insulin or immunosuppression, according to new ...

The iPSC clinical line that generated these insulin producing Islet Cells is part of the Company’s iPSCelz ® program, which is validated by Greenstone Biosciences Inc. (“Greenstone”).